Copyright
©The Author(s) 2021.
World J Clin Cases. Feb 16, 2021; 9(5): 1184-1195
Published online Feb 16, 2021. doi: 10.12998/wjcc.v9.i5.1184
Published online Feb 16, 2021. doi: 10.12998/wjcc.v9.i5.1184
Ref. | Age in yr/gender | Sites | Tumor histology | Treatment | Outcome | Follow-up |
Li et al[22], 2020 | 67/F | Uterine | Moderately differentiated endometrial cancer | Surgery RT CT ET | DFS | 19 mo |
Colon | Ascending colon papillary adenocarcinoma and moderately differentiated tubular adenocarcinoma | |||||
Breast | Invasive ductal carcinoma | |||||
Feng et al[23], 2018 | 66/M | Prostate | Acinar adenocarcinoma | Surgery CT | DFS | 4 mo |
Colon | Moderately differentiated adenocarcinoma | |||||
Lung | Moderately differentiated adenocarcinoma | |||||
Gheonea et al[24], 2017 | 75/M | Prostate | Prostate carcinoma | ET | NM | NM |
Lung | Small lung cell carcinoma | |||||
Skin | Basal cell carcinoma | |||||
Kim et al[25], 2017 | 73/M | Lung | Small cell carcinoma | Surgery CT | DFS | 44 mo |
Poorly differentiated adenocarcinoma | ||||||
Moderately differentiated squamous cell carcinoma | ||||||
Yoshikawa et al[26], 2017 | 60/M | Bile duct | Papillary adenocarcinoma | Surgery CT RT | DFS | NM |
Poorly differentiated cholangio cellular carcinoma | ||||||
A well-differentiated hilar cholangiocarcinoma | ||||||
Pastore et al[27], 2015 | 70/M | Renal | Renal clear cell carcinoma | Surgery RT CT ET | NM | NM |
Oropharynx | Poorly-differentiated (G3) squamous cell carcinoma | |||||
Prostate | Adenocarcinoma | |||||
Nishikawa et al[28], 2014 | 37/M | Hypopharynx | Squamous cell carcinoma | Surgery RT CT | DOD | 10 yr |
Esophagus | ||||||
Tongue | ||||||
Okumura et al[29], 2013 | 73/M | Prostatic | Moderately differentiated adenocarcinoma | NM | NM | NM |
Bladder | Grade 2 urothelial carcinoma | |||||
Renal | Grade 2 clear renal cell carcinoma | |||||
Zargar-Shoshtari et al[30], 2013 | 71/M | Renal | Clear renal cell carcinoma | Surgery ET | DOD | 1 yr |
Prostate | Adenocarcinoma | |||||
Breast | Poorly differentiated invasive ductal cell carcinoma | |||||
Freeman[31], 2013 | 72/M | Colon | Moderately differentiated adenocarcinoma in the distal sigmoid colon | Surgery | DFS | 15 yr |
Infiltrative moderately differentiated colonic | ||||||
Adenocarcinoma in the descending colon moderately differentiated adenocarcinoma in the rectum | ||||||
Chang et al[32], 2013 | 67/M | Maxillary sinus | Adenoid cystic carcinoma | Surgery RT | DFS | 15 yr |
Esophagus | Squamous cell carcinoma | 22 mo | ||||
Tympanic membrane | 18 mo | |||||
Egashira et al[33], 2013 | 63/F | Esophagus | Esophageal cancer | Surgery | DFS | 10 mo |
Colon | Ascending colon cancer | |||||
Jejunum | Jejunal cancer | |||||
Takalkar et al[34], 2013 | 64/F | Small intestine | Moderately differentiated adenocarcinoma | Surgery CT | NM | NM |
Breast | Well differentiated infiltrated duct carcinoma | |||||
Ovary | Papillary adenocarcinoma | |||||
Arikan-Sengul et al[35], 2009 | 70/M | Bladder | Transitional cell carcinoma | NM | NM | NM |
Prostate | ||||||
Renal | Renal cell carcinoma | |||||
Yamanaka et al[36], 2008 | 24/F | Humerus | Steosarcoma | Surgery CT | NM | NM |
Breast | The light breast cancer the left breast cancer | |||||
Oztop et al[37], 2008 | 76/M | Rectum | Metastatic rectal cancer | Surgery CT RT ET | DOD | 1 yr |
Prostate | Prostate cancer | |||||
Lymphocyte | Philadelphia (+) chronic myeloid leukemia | |||||
Baba et al[38], 2002 | 64/M | Lung | Small cell lung cancer | Surgery | DFS | 20 mo |
Prostate | Moderately or poorly differentiated adenocarcinoma | |||||
Breast | Scirrhous carcinoma | |||||
Iioka et al[39], 2000 | 60/M | Colon | Sigmoid colon cancer | Surgery RT | DOD | 13 mo |
Stomach | Early gastric cancer | |||||
Esophagus | The middle thoracic esophagus cancer | |||||
Saitoh et al[40], 1995 | 64/M | Lung | Moderately differentiated squamous cell carcinoma | Surgery RT | NM | NM |
Colon | The rectum carcinoma | |||||
Trachea | Moderately differentiated squamous cell carcinoma with mediastinal lymph node metastasis |
- Citation: Peng WX, Liu X, Wang QF, Zhou XY, Luo ZG, Hu XC. Heterochronic triple primary malignancies with Epstein-Barr virus infection and tumor protein 53 gene mutation: A case report and review of literature. World J Clin Cases 2021; 9(5): 1184-1195
- URL: https://www.wjgnet.com/2307-8960/full/v9/i5/1184.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i5.1184